Page 1 of 16 Open-Label Evaluation of a Novel Skin Brightening System Containing 0.01% Decapeptide-12 for the Treatment of Mild to Moderate Facial Melasma Ramírez SP
نویسندگان
چکیده
1Consultorio Sandra Ramírez, M.D.: calle 4 sur # 43 a 195 El Centro Ejecutivo oficina 253 C Medellín, Colombia 2Consultorio Alfonso Carvajal, M.D.: calle 4 sur # 43 a 195 El Centro Ejecutivo oficina 253 C Medellín, Colombia 3Consultorio Juan Carlos Salazar, M.D.: Bioestética: Calle 2 Sur No. 46 55 Consultorios 219 y 230 Clínica Las Vegas Medellín, Colombia 4Consultorio Gladys Arroyave, M.D.: Carrera 48 # 32 B sur 30 4° piso. Clínica Nova 5Consultorio Ana María Flórez, M.D.: carrera 46 numero 2 sur 55 consultorio 423 Clínica Las Vegas – Medellín, Colombia 6Consultorio Hector Echeverry, M.D. (Estetica & Laser) carrera 48 # 10-45 interior 949 torre empresarial Monterrey, Medellín, Colombia
منابع مشابه
Open-label evaluation of the skin-brightening efficacy of a skin-brightening system using decapeptide-12.
This prospective study evaluated the safety and efficacy of decapeptide-12 in conjunction with an antioxidant cleanser, glycolic-acid containing facial moisturizer and broad-spectrum sunscreen in the treatment of facial hyperpigmentation associated with chronic photodamage. Fifteen female subjects with Fitzpatrick skin types I through IV and documented photodamage were entered into the study, o...
متن کاملHydroquinone 4%, tretinoin 0.05%, fluocinolone acetonide 0.01%: a safe and efficacious 12-month treatment for melasma.
This article describes a long-term, multicenter, open-label, 12-month study of once-daily fluocinolone acetonide 0.01%, hydroquinone 4%, tretinoin 0.05% (Tri-Luma Cream, hereinafter called TC [triple combination]) application in the treatment of melasma. A total of 228 patients with facial melasma were enrolled and treated; 173 patients (76%) completed the study. Most patients had 1 to 2 course...
متن کاملA split-face, double-blind, randomized and placebo-controlled pilot evaluation of a novel oligopeptide for the treatment of recalcitrant melasma.
Melasma is a cutaneous disorder associated with an overproduction of melanin by the tyrosinase enzyme. A proprietary oligopeptide (Lumixyl) was previously shown to competitively inhibit mushroom and human tyrosinase without the associated toxicity of hydroquinone. The aim of this split-face, randomized, double-blind and placebo-controlled pilot study was to determine the effect of twice-daily t...
متن کاملEvaluation of Licorice efficacy on melasma
Treatment of melasma has remained a hottopic in dermatology because of its resistance totherapy and high recurrence rate. For many yearshydroquinone was the foundation of melasmatreatment, but its use has been limited during theseyears due to a number of adverse events, suchas skin irritation, hyper and hypo pigmentation,nail discoloration, conjunctival melanosis andochronosis. Furthermore hydr...
متن کاملEfficacy of Melaleuca alternifolia Essential Oil in the Treatment of Facial Seborrheic Dermatitis: A Double-blind, Randomized, Placebo-Controlled Clinical Trial
Background: Melaleuca alternifolia (tea tree) essential oil has been traditionally used in the ayurvedic system of medicine for healing burns, infections and seborrheic dermatitis. But yet, no controlled human study has determined its efficacy. Objective: The goal of the current study was to compare the efficacy of 5% tea tree essential oil (TTO) gel with placebo in the treatment of mild to m...
متن کامل